Search for an ETF or holding
Aardvark Therapeutics, Inc. (AARD) is an American company in the healthcare sector, listed on NASDAQ. Market capitalization of 83 million USD (micro-cap).
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.